These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 367896)

  • 41. [Anorectal malignant melanomas. Apropos of 5 cases. Review of the literature].
    Melhouf MM; el Amrani N; Mathieu-Daude H; Dubois JB
    Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):209-12. PubMed ID: 7486817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Possibilities of nonspecific immunotherapy with BCG in malignant melanomas of the skin].
    Romano S; Ziccardi M; Muzio GF; Filippi B
    Arch Maragliano Patol Clin; 1976; 32():114-21. PubMed ID: 802769
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
    Iavorskiĭ VV; Karaseva VV; Tokareva ZI
    Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Disseminated melanoma treatment].
    Neidhardt-Bérard EM; Négrier S
    Rev Prat; 2004 Jun; 54(11):1210-4. PubMed ID: 15496028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 47. [Polychemotherapy of metastatic melanoma. Preliminary report].
    Laugier P; Orusco M; Wagenknecht L; Jaccard MA
    Dermatologica; 1972; 145(2):72-9. PubMed ID: 4666073
    [No Abstract]   [Full Text] [Related]  

  • 48. [General principles and new trends of cytostatic tumor therapy].
    Holfeld H; Bamberg M
    Strahlentherapie; 1980 May; 156(5):297-307. PubMed ID: 7190333
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic evaluation of human malignant melanoma by urinary 5-S-cysteinyldopa dynamics: chemotherapy and surgery].
    Inoi T; Mojamdar M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1984 Jan; 94(1):39-43. PubMed ID: 6433083
    [No Abstract]   [Full Text] [Related]  

  • 51. [Histological and histochemical studies on melanoma metastases under immunobiological and cytostatic therapy].
    Schneider I; Aulepp H; Gartmann H
    Z Hautkr; 1976 Feb; 51(3):81-90. PubMed ID: 60839
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients.
    Berkelhammer J; Mastrangelo MJ; Bellet RE; Berd D; Prehn RT
    Eur J Cancer (1965); 1979 Feb; 15(2):197-204. PubMed ID: 436896
    [No Abstract]   [Full Text] [Related]  

  • 53. Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.
    Grooms GA; Eilber FR; Morton DL
    J Surg Oncol; 1977; 9(2):147-53. PubMed ID: 325299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant melanoma of the rectal ampulla: report of a case and review of the literature.
    Alexander RM; Cone LA
    Dis Colon Rectum; 1977; 20(1):53-5. PubMed ID: 318982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The survival of patients with malignant melanoma receiving BCG with or without chemotherapy.
    Green MD; MacKay IR; Buckley JC; Coates AS
    Aust N Z J Surg; 1979 Jun; 49(3):335-9. PubMed ID: 289374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemoimmunotherapy of human solid tumors.
    Gutterman JU; Mavligit GM; Hersh EM
    Med Clin North Am; 1976 May; 60(3):441-62. PubMed ID: 1063907
    [No Abstract]   [Full Text] [Related]  

  • 57. Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.
    Serrou B; Pujol H; Domas J; Gauci L
    Recent Results Cancer Res; 1978; 68():363-6. PubMed ID: 752871
    [No Abstract]   [Full Text] [Related]  

  • 58. Fotemustine with or without dacarbazine for brain metastases of malignant melanoma.
    Merimsky O; Inbar M; Reider-Groswasser I; Chaitchik S
    Eur J Cancer; 1991; 27(8):1066. PubMed ID: 1832900
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
    Cohen SM; Greenspan EM; Ratner LH; Weiner MJ
    Cancer; 1977 Jan; 39(1):41-4. PubMed ID: 832250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current status of melanoma chemotherapy and immunotherapy.
    Czarnetzki BM; Macher E; Behrendt H; Lejeune F
    Recent Results Cancer Res; 1982; 80():264-8. PubMed ID: 7036291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.